Nikhil Gupta

Thank you for the opportunity. My first question is on our Australia market. I think we have received an MA for a particular benzoate. When we can expect the revenues start flowing from that product?

Sorry. I'm not very clear. This slide, I think, I'm not able to see any CAPA on the Australia side in the presentation. Yeah, in the slide, which is basically telling you about the EU-GMP remediation, at the bottom there is a note where we have said that we did undergo a TGA audit, a slide number 6 of the presentation. The TGA is like for EU, there is EMA, the European Medicine Agencies.

Right. It's clear. So, how much big is the market for that particular product in Australia?